Coronavirus Outbreak: F1 team Mercedes helps develop breathing aid in conjunction with University College London
Mercedes worked with engineers at the University College London and clinicians at University College London Hospital to adapt and improve a device that bridges the gap between an oxygen mask and the need for full ventilation
London: Formula One team Mercedes has helped to develop a breathing aid that could keep coronavirus patients out of intensive care and ease some pressure on Britain’s strained health service.
Mercedes worked with engineers at the University College London and clinicians at University College London Hospital to adapt and improve a device that bridges the gap between an oxygen mask and the need for full ventilation.
The device, known as continuous positive airway pressure, has been used extensively in hospitals in Italy and China to deliver oxygen to the lungs of coronavirus patients during the pandemic.
UCL said the adapted devices have been recommended for use in Britain and that 100 of them are being sent to its hospital for clinical trials. There is the potential for quick roll-out by Mercedes to hospitals across the country.
Tim Baker, a professor from UCL’s department of mechanical engineering, said clinicians called on the “capability of Formula One” to reduce a process “that could take years down to a matter of days,” with the adapted device taking less than 100 hours to develop from an initial meeting.
"We have been proud to put our resources at the service of UCL,” said Andy Cowell, managing director of Mercedes, “to deliver the CPAP project to the highest standards and in the fastest possible time frame."
CPAP machines work by pushing a mix of oxygen and air into the mouth and nose at a continuous rate, helping to increase the amount of oxygen entering the lungs. They are used routinely by Britain’s National Health Service but are in short supply currently.
There have been almost 20,000 confirmed cases of COVID-19 in Britain, with more than 1,200 deaths.
For most people, the new virus causes mild or moderate symptoms, such as fever and cough that clear up in two to three weeks. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia and death.
The F1 season has yet to start, with the first eight races of the schedule having been postponed or canceled. It means there will be no racing until the middle of June at the earliest.
Mercedes is the leading team in F1 with defending champion Lewis Hamilton as its top driver.
AstraZeneca vaccine has higher efficacy against COVID-19 with a three-month gap between doses, says Oxford study
The study, published in The Lancet, suggests that the interval between doses can be safely extended to three months than a six-week gap as the first dose can offer up to 76 percent protection during that period
Passengers arriving from Maharashtra, Kerala, Karnataka and Telangana should undergo RT-PCR tests within 72 hours of the flight's departure
India's slow COVID-19 vaccination rate puts gains at peril; private sector involvement must to expand coverage
It is important to reiterate that the argument of 'natural herd immunity' remains largely a thereotical one, and cannot be relied on to mitigate the disease, especially with millions of vaccine doses ready